Vanda Pharmaceuticals Shares Are Trading Higher After the US Supreme Court Reportedly Declined to Hear the Company's Case Regarding the Invalidation of Patents for Hetlioz
据报道,美国最高法院拒绝审理该公司有关Hetlioz专利无效的案件,此后,万达制药股价走高
Vanda Pharmaceuticals Shares Are Trading Higher After the US Supreme Court Reportedly Declined to Hear the Company's Case Regarding the Invalidation of Patents for Hetlioz
据报道,美国最高法院拒绝审理该公司有关Hetlioz专利无效的案件,此后,万达制药股价走高
使用浏览器的分享功能,分享给你的好友吧